O -Glycome Profiling of Breast Cancer Cell Lines to Understand Breast Cancer Brain Metastasis.

Breast cancer is the second leading cause of cancer-related death among women and a major source of brain metastases. Despite the increasing incidence of brain metastasis from breast cancer, the underlying mechanisms remain poorly understood. Altered glycosylation is known to play a role in various diseases including cancer metastasis. However, profiling studies of O -glycans and their isomers in breast cancer brain metastasis (BCBM) are scarce. This study analyzed the expression of O -glycans and their isomers in human breast cancer cell lines (MDA-MB-231, MDA-MB-361, HTB131, and HTB22), a brain cancer cell line (CRL-1620), and a brain metastatic breast cancer cell line (MDA-MB-231BR) using nanoLC-MS/MS, identifying 27 O -glycan compositions. We observed significant upregulation in the expression of HexNAc 1 Hex 1 NeuAc 2 and HexNAc 2 Hex 3 , whereas the expression of HexNAc 1 Hex 1 NeuAc 1 was downregulated in MDA-MB-231BR compared to other cell lines. In our isomeric analysis, we observed notable alterations in the isomeric forms of the O -glycan structure HexNAc 1 Hex 1 NeuAc 1 in a comparison of different cell lines. Our analysis of O -glycans and their isomers in cancer cells demonstrated that changes in their distribution can be related to the metastatic process. We believe that our investigation will contribute to an enhanced comprehension of the significance of O -glycans and their isomers in BCBM.